Benznidazole therapy modulates interferon-γ and M2 muscarinic receptor autoantibody responses in trypanosoma cruzi-infected children

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Cutrullis, Romina A ^a   Moscatelli, Guillermo F ^a   Moroni, Samanta ^a   Volta, Bibiana J ^b   Cardoni, Rita L ^b   Altcheh, Jaime M ^a   Corral, Ricardo S ^a   Freilij, Héctor L ^a   Petray, Patricia B ^a  

^a HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^b Administracion Nacional de Laboratorios E Institutos de Salud Dr Carlos G Malbran   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; GAMMA INTERFERON; MUSCARINIC M2 RECEPTOR; AUTOANTIBODY; NITROIMIDAZOLE DERIVATIVE;

ADOLESCENT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CHAGAS DISEASE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; IMMUNOREACTIVITY; INTERFERON PRODUCTION; MALE; NEUROTRANSMISSION; PRESCHOOL CHILD; SCHOOL CHILD; SEROLOGY; TRYPANOSOMA CRUZI; BLOOD; CASE CONTROL STUDY; IMMUNOLOGY; PARASITOLOGY; TREATMENT OUTCOME;

TRYPANOSOMA CRUZI;

ADOLESCENT; AUTOANTIBODIES; CASE-CONTROL STUDIES; CHAGAS DISEASE; CHILD; FEMALE; HUMANS; INTERFERON-GAMMA; MALE; NITROIMIDAZOLES; RECEPTOR, MUSCARINIC M2; TREATMENT OUTCOME; TRYPANOSOMA CRUZI;

EID: 80055112444     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027133     Document Type: Article

References (38)

1. World Health Organization (2007) Reporte del grupo de trabajo científico sobre la enfermedad de Chagas. Eds.: Guhl F; Lazdins-Helds JK. Available: http://apps.who.int/tdr/publications/tdr-research-publications/reporte-enfermedad-chagas/pdf. Accessed 2011 Sep 2.
2. Bilate AM, Cunha-Neto E, (2008) Chagas disease cardiomyopathy: current concepts of an old disease. Rev Inst Med Trop Sao Paulo 50: 67-74.
3. Hagar JM, Rahimtoola SH, (1995) Chagaś heart disease. Curr Problem Cardiol 20: 825-924.
4. Milei J, Storino R, Jorg M, Chiale P, Schetjman D, et al. (1994) Patogenia. In: Storino R, Milei J, editors. Enfermedad de Chagas Buenos Aires Doyma pp. 103-128.
5. Manzullo EC, Chuit R, (1999) Risk of death due to chronic chagasic cardiopathy. Mem Inst Oswaldo Cruz 94: 317-320.
6. Tarleton RL, (2001) Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31: 550-554.
7. Leon JS, Godsel LM, Wang K, Engman DM, (2001) Cardiac myosin autoimmunity in acute Chagaś heart disease. Infect Immun 69: 5643-5649.
8. Rocha MOC, Ribeiro AL, Teixeira MM, (2003) Clinical management of chronic Chagasic cardiomyopathy. Frontiers Biosci 8: e44-54.
9. Borda ES, Sterin-Borda L, (1996) Antiadrenergic and muscarinic receptor antibodies in Chagaś cardiomyopathy. Int J Cardiol 54: 149-156.
10. Ribeiro AL, Moraes RS, Ribeiro JP, Ferlin EL, Tores RM, et al. (2001) Parasympathetic dysautonomia precedes left ventricular systolic dysfunction in Chagas disease. Am Heart J 141: 260-265.
11. Ribeiro ALP, Díaz Giménez LE, Quintero Hernández CC, Campos de Carvalho AC, Teixeira MM, et al. (2007) Early occurrence of anti-muscarinic autoantibodies and abnormal vagal modulation in Chagas disease. Int J Cardiol 117: 59-63.
12. Ferrari I, Levin MJ, Wallukat G, Elies R, Lebesgue D, et al. (1995) Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human β1-adrenergic receptor. J Exp Med 182: 59-65.
13. Labovsky V, Smulski CR, Gómez K, Levy G, Levin MJ, (2007) Anti-β1-adrenergic receptor autoantibodies in patients with chronic Chagas heart desease. Clin Exp Immunol 148: 440-449.
14. Gutiérrez FR, Guedes PM, Gazzinelli RT, Silva JS, (2009) The role of parasite persistence in pathogenesis of Chagas heart disease. Parasite Immunol 31: 673-685.
15. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Gazzinelli G, et al. (2003) Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
16. Corrêa-Oliveira R, de Assis Silva Gomes J, Moreira Lemos E, Meira Cardoso G, Reis DD, et al. (1999) The role of the immune response on the development of severe clinical forms of human Chagas disease. Mem Inst Oswaldo Cruz 94: 253-255.
17. Cunha-Neto E, Nogueira LG, Teixeira PC, Ramasawmy R, Drigo SA, et al. (2009) Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz 104: 252-258.
18. Olivieri BP, Cotta-De-Almeida V, Araujo-Jorge T, (2002) Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+T-cell expansion and promotes resistance to reinfection. Antimicrob Agents Chemother 46: 3790-3796.
19. Villinger F, Hunt D, Mayne A, Vuchetich M, Findley H, et al. (1993) Qualitative and quantitative studies of cytokines synthesized and secreted by non-human primate peripheral blood mononuclear cells. Cytokine 5: 469-479.
20. Goin JC, Borda ES, Auger S, Storino R, Sterin-Borda L, (1999) Cardiac M2 muscarinic cholinoreceptor activation by human chagasic autoantibodies: association with bradycardia. Heart 82: 273-278.
21. García S, Ramos CO, Senra JFV, Vilas-Boas F, Rodriguez MM, et al. (2005) Treatment with benznidazole during the chronic phase of experimental Chagaśdisease decreases cardiac alterations. Antimicrob Agents Chemother 49: 1521-1528.
22. Benchimol-Barbosa PR, (2011) Comments on the article by Ribeiro,et al. 'Enhanced parasympathetic activity in Chagas' disease still stands in need of proof': definitions and biases. Int J Cardiol 146: 88-90.
23. Nussinovitch U, Shoenfeld Y, (2011) The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies. Clin Rev Allergy Immunol Jan 5[Epub ahead of print].
24. Giménez L, Mitelman J, González C, Borda E, Sterin-Borda L, (2003) Anticuerpos anti-receptores autonómicos, alteraciones de la variabilidad de la frecuencia cardíaca y arritmias en sujetos con Enfermedad de Chagas. Rev Arg Cardiol 71: 109-113.
25. Talvani A, Rocha MOC, Ribeiro AL, Borda E, Sterin-Borda L, et al. (2006) Levels of anti-M2 and anti-β1 autoantibodies do not correlate with the degree of heart dysfunction in Chagaśheart disease. Microbes Infect 8: 2459-2464.
26. Goin JC, Borda ES, Pérez Leirós C, Storino R, Sterin-Borda L, (1994) Identification of antibodies with muscarinic cholinergic activity in human Chagaś disease: pathological implications. J Auton Nerv Syst 47: 45-52.
27. Cutrullis RA, Ballering G, Altcheh J, Moscatelli G, Corral R, et al. (2007) Anti-M2 muscarinic receptor autoantibodies in Trypanosoma cruzi-infected pediatric patients treated with benznidazole. Rev Patol Trop 36: 141-148.
28. Peraza-Cruces K, Gutiérrez-Guédez L, Castañeda Perozo D, Lankford CR, Rodríguez-Bonfante C, et al. (2008) Trypanosoma cruzi infection induces up-regulation of cardiac muscarinic acetylcholine receptors in vivo and in vitro. Braz J Med Biol Res 41: 796-803.
29. de Andrade AL, Zicker F, Rassi A, Rassi AG, Oliveira RM, et al. (1998) Early electrocardiographic abnormalities in Trypanosoma cruzi-seropositive children. Am J Trop Med Hyg 59: 530-534.
30. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simões MV, et al. Pathogenesis of Chronic Chagas Heart Disease. Circulation 115: 1109-1123.
31. Pérez Leirós C, Goren N, Sterin-Borda L, Borda ES, (1997) Myocardial dysfunction in an experimental model of autoimmune myocarditis: role of IFN-γ. Neuroimmunomodulation 4: 91-97.
32. Samudio M, Montenegro-James S, Cabral M, Martinez J, Rojas de Arias A, (1998) Cytokine responses in Trypanosoma cruzi-infected children in Paraguay. Am J Trop Med Hyg 58: 119-121.
33. Laucella SA, Pérez Mazliah D, Bertocchi G, Alvarez MG, Cooley G, et al. (2009) Changes in Trypanosoma cruzi-Specific Immune Responses after Treatment: Surrogate Markers of Treatment Efficacy. Clin Infect Dis 49: 1675-1684.
34. Bahia-Oliveira LM, Gomes JA, Rocha MO, Moreira MC, Lemos EM, et al. (1998) IFN-gamma in human Chagas' disease: protection or pathology?. Braz J Med Biol Res 31: 127-131.
35. Borda E, Leirós CP, Sterin-Borda L, de Bracco MM, (1991) Cholinergic response of isolated rat atria to recombinant rat interferon-gamma. J Neuroimmunol 32: 53-59.
36. Piaggio E, Roggero E, Pitashny M, Wiertzerbin J, Bottasso OA, et al. (2001) Treatment with benznidazole and its immunomodulating effects on Trypanosoma cruzi-infected rats. Parasitol Res 87: 539-547.
37. Moretti E, Basso B, Cervetta L, Brigada A, Barbieri G, (2002) Patterns of cytokines and soluble cellular receptors in the sera of children with acute Chagaśdisease. Clin Diagn Lab Immunol 9: 1324-1237.
38. Altcheh J, Biancardi M, Lapeña A, Ballering G, Freilij H, (2005) Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutiérrez, Buenos Aires, Argentina. Rev Soc Bras Med Trop 38: 41-45.